- Home
- OII vs ACAD Comparison
OII vs ACAD Comparison
Compare OII & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OII
- ACAD
- Stock Information
- Founded
- OII 1964
- ACAD 1993
- Country
- OII United States
- ACAD United States
- Employees
- OII N/A
- ACAD N/A
- Industry
- OII Oilfield Services/Equipment
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- OII Energy
- ACAD Health Care
- Exchange
- OII Nasdaq
- ACAD Nasdaq
- Market Cap
- OII 2.8B
- ACAD 2.6B
- IPO Year
- OII N/A
- ACAD 2004
- Fundamental
- Price
- OII $27.97
- ACAD $16.27
- Analyst Decision
- OII Buy
- ACAD Buy
- Analyst Count
- OII 4
- ACAD 19
- Target Price
- OII $27.00
- ACAD $26.44
- AVG Volume (30 Days)
- OII 859.3K
- ACAD 1.4M
- Earning Date
- OII 10-23-2024
- ACAD 11-06-2024
- Dividend Yield
- OII N/A
- ACAD N/A
- EPS Growth
- OII 76.07
- ACAD N/A
- EPS
- OII 1.32
- ACAD 0.78
- Revenue
- OII $2,602,340,000.00
- ACAD $929,236,000.00
- Revenue This Year
- OII $9.75
- ACAD $35.78
- Revenue Next Year
- OII $7.25
- ACAD $8.58
- P/E Ratio
- OII $21.17
- ACAD $20.96
- Revenue Growth
- OII 12.84
- ACAD 47.06
- 52 Week Low
- OII $18.67
- ACAD $14.15
- 52 Week High
- OII $30.45
- ACAD $32.59
- Technical
- Relative Strength Index (RSI)
- OII 59.57
- ACAD 51.85
- Support Level
- OII $27.05
- ACAD $16.37
- Resistance Level
- OII $27.97
- ACAD $18.71
- Average True Range (ATR)
- OII 1.00
- ACAD 0.73
- MACD
- OII 0.06
- ACAD 0.00
- Stochastic Oscillator
- OII 74.28
- ACAD 43.26
About OII Oceaneering International Inc.
Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.